How Rising Chronic Pain Prevalence and Aging Population Are Driving the Global NSAID Market
The global Non-Steroidal Anti-Inflammatory Drug market is expanding as pharmaceutical companies, hospitals, and pharmacies invest in advanced pain management solutions to address the rising incidence of chronic pain, arthritis, and inflammatory conditions. The market was valued at USD 37.19 billion in 2024 and is projected to reach USD 50.01 billion by 2035, growing at a CAGR of 2.73%. The...
0 Comments 0 Shares 131 Views 0 Reviews